ANI Pharmaceuticals, Inc.

NASDAQ:ANIP

Drug Manufacturers - Specialty & Generic

Healthcare
$71.47 -1.76%

-$1.42 today

Market cap
$1.62B
Beta
0.44
P/E (TTM)
18.5
EPS (TTM)
$4.29
52W Low $62.61High $99.50

Volume 0.29M

Average 0.35M

ANIP Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

ANI Pharmaceuticals, Inc.NASDAQ: ANIP

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 20.91M shares rose 6.7% year over year, ahead of the +4.0% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 4.3% from the prior quarter. Over 3 fiscal years it compounded at +7.2% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +6.7% holds above the trailing-twelve-month pace of +4.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
20.91M+4.3% QoQ
Last fiscal yearDec 2025
20.05M+3.8% YoY
LTMMar 2026
20.22M+4.0% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.7%——
1 year+3.8%——
3-year CAGR+7.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
20.05M USD
Year-over-year change
+3.8%
4-year CAGR
+12.3%

Weighted Avg Shares vs competitors

How ANIP compares with its peers on the latest reported figures

  • ANIP's LTM Mar 2026 weighted avg shares of 20.22M shares is the lowest of the 11 companies compared; the peer median is 190.21M shares.
  • Its year-over-year change of +4.0% is the highest of 10, against a peer median of +0.6%.
  • Over three fiscal years its annual growth of +7.2% compares with a peer median of +1.0%.
ANIP Competitors Peer median
Weighted Avg Shares for ANIP and competitors
Company Period LTM YoY 3-year CAGR
VTRSViatris Inc.LTM Jun 20261.16B -2.4%-1.2%
TEVATeva Pharmaceutical Industries LimitedLTM Jun 20261.15B +1.5%+1.2%
RDYDr. Reddy's Laboratories LimitedLTM Sep 2026833.5M +0.1%+0.1%
BHCBausch Health Companies Inc.LTM Jun 2026372.41M +0.6%+0.8%
AMRXAmneal Pharmaceuticals, Inc.LTM Jun 2026315.69M +1.5%+27.6%
EOLSEvolus, Inc.LTM Mar 202664.73M +3.0%+4.8%
AMPHAmphastar Pharmaceuticals, Inc.LTM Mar 202646.16M -4.6%-1.3%
LFCRLifecore Biomedical, Inc.LTM Mar 202637.34M —+5.7%
HROWHarrow Health, Inc.LTM Mar 202636.98M +3.5%+10.2%
COLLCollegium Pharmaceutical, Inc.LTM Mar 202631.79M -1.1%-2.1%
ANIPANI Pharmaceuticals, Inc.LTM Mar 202620.22M +4.0%+7.2%
Peer median (excluding ANIP) 190.21M+0.6%+1.0%

Competitors are the stored peer set for ANIP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue216.14M316.39M486.82M614.38M883.37M
Cost of Revenue100.61M138.79M181.51M250.21M432.73M
Gross Profit115.53M177.6M305.3M364.17M450.64M
Gross Margin53.5%56.1%62.7%59.3%51.0%
Research & Development11.37M22.32M34.29M44.58M51.66M
Selling, General & Admin84.29M124.04M161.7M249.64M317.75M
Operating Expenses155.32M212.88M258.33M363.58M369.41M
Depreciation & Amortization47.25M59.65M59.79M67.73M91.42M
EBITDA3.12M25.04M106.6M63.12M207.27M
EBITDA Margin1.4%7.9%21.9%10.3%23.5%
Operating Income(39.79M)(35.28M)46.97M584K81.23M
Operating Margin-18.4%-11.2%9.6%0.1%9.2%
Interest Income00000
Interest Expense11.92M28.05M26.94M17.6M20.06M
Other Income / Expenses(16.27M)(27.38M)(27.1M)(22.8M)14.56M
Income Before Tax(56.06M)(62.67M)19.87M(22.21M)95.79M
Pre-Tax Margin-25.9%-19.8%4.1%-3.6%10.8%
Income Tax Expense(13.46M)(14.77M)1.09M(3.69M)17.45M
Net Income(42.6M)(47.9M)18.78M(18.52M)78.34M
Net Margin-19.7%-15.1%3.9%-3.0%8.9%
EPS (Basic)(3.40)(3.05)0.95(1.04)3.50
EPS (Diluted)(3.40)(3.05)0.94(1.04)3.32
Weighted Avg Shares12.6M16.26M18M19.32M20.05M
Weighted Avg Shares (Diluted)12.6M16.26M18.19M19.32M21.23M

ANI Pharmaceuticals, Inc.

NASDAQ:ANIP

Intrinsic Alpha fair value

Locked

Current Price

$71.47

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.